Overview

Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes

Status:
Unknown status
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study the effects of polyarginine treated vein grafts on graft patency for patients undergoing coronary artery bypass surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
St. Luke's Hospital, Chesterfield, Missouri
Treatments:
Pharmaceutical Solutions